Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?
The concept of the gut microbiome is emerging as a metabolic interactome influenced by
diet, xenobiotics, genetics, and other environmental factors that affect the host's absorption …
diet, xenobiotics, genetics, and other environmental factors that affect the host's absorption …
[HTML][HTML] Brain neurotransmitter modulation by gut microbiota in anxiety and depression
F Huang, X Wu - Frontiers in cell and developmental biology, 2021 - frontiersin.org
Anxiety and depression are highly prevalent mental illnesses worldwide and have long
been thought to be closely associated to neurotransmitter modulation. There is growing …
been thought to be closely associated to neurotransmitter modulation. There is growing …
Dopamine in health and disease: much more than a neurotransmitter
Dopamine is derived from an amino acid, phenylalanine, which must be obtained through
the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher …
the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher …
Reinforcement learning in depression: A review of computational research
C Chen, T Takahashi, S Nakagawa, T Inoue… - … & Biobehavioral Reviews, 2015 - Elsevier
Despite being considered primarily a mood disorder, major depressive disorder (MDD) is
characterized by cognitive and decision making deficits. Recent research has employed …
characterized by cognitive and decision making deficits. Recent research has employed …
Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome
M Chen, G Ruan, L Chen, S Ying, G Li, F Xu… - Frontiers in …, 2022 - frontiersin.org
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder of unknown etiology.
IBS is caused by a disruption in the gut-brain axis. Given the importance of the gut …
IBS is caused by a disruption in the gut-brain axis. Given the importance of the gut …
An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression
S Durgam, W Earley, A Lipschitz… - American Journal of …, 2016 - Am Psychiatric Assoc
Objective: The authors evaluated the efficacy, safety, and tolerability of cariprazine, an
atypical antipsychotic candidate, in adult patients with acute bipolar I depression. Method …
atypical antipsychotic candidate, in adult patients with acute bipolar I depression. Method …
Burning mouth syndrome: a systematic review of treatments
YF Liu, Y Kim, T Yoo, P Han, JC Inman - Oral diseases, 2018 - Wiley Online Library
Burning mouth syndrome (BMS) is a chronic oral pain syndrome that primarily affects peri‐
and postmenopausal women. It is characterized by oral mucosal burning and may be …
and postmenopausal women. It is characterized by oral mucosal burning and may be …
[HTML][HTML] Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
P Yang, JS Perlmutter, TLS Benzinger, JC Morris… - Ageing research …, 2020 - Elsevier
Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms which relentlessly and progressively lead to substantial disability and …
motor symptoms which relentlessly and progressively lead to substantial disability and …
Neuronal dopamine D3 receptors: translational implications for preclinical research and CNS disorders
B Kiss, I Laszlovszky, B Krámos, A Visegrády, A Bobok… - Biomolecules, 2021 - mdpi.com
Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS)
and periphery, exerts its actions through five types of receptors which belong to two major …
and periphery, exerts its actions through five types of receptors which belong to two major …
Dopamine receptors: is it possible to become a therapeutic target for depression?
F Zhao, Z Cheng, J Piao, R Cui, B Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Dopamine and its receptors are currently recognized targets for the treatment of several
neuropsychiatric disorders, including Parkinson's disease, schizophrenia, some drug use …
neuropsychiatric disorders, including Parkinson's disease, schizophrenia, some drug use …